Investors Title extends poison pill to 2032, raises purchase price to $525

INVESTORS TITLE CO

Rights agreement extended from Oct 31, 2022 to Sep 30, 2032.
Purchase price increased from $220 to $525 per one-hundredth of a preferred share.
New 'Acting in Concert' definition triggers rights when parties act together to influence control.
Other technical and conforming changes made to the agreement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.